Besmir Nreu

1.5k total citations
36 papers, 1.1k citations indexed

About

Besmir Nreu is a scholar working on Endocrinology, Diabetes and Metabolism, Oncology and Epidemiology. According to data from OpenAlex, Besmir Nreu has authored 36 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Oncology and 8 papers in Epidemiology. Recurrent topics in Besmir Nreu's work include Diabetes Treatment and Management (23 papers), Neuroendocrine Tumor Research Advances (7 papers) and Diabetes Management and Research (7 papers). Besmir Nreu is often cited by papers focused on Diabetes Treatment and Management (23 papers), Neuroendocrine Tumor Research Advances (7 papers) and Diabetes Management and Research (7 papers). Besmir Nreu collaborates with scholars based in Italy. Besmir Nreu's co-authors include Edoardo Mannucci, Matteo Monami, Ilaria Dicembrini, Giorgio Sesti, Alessia Scatena, Francesco Andreozzi, Stefania Zannoni, Barbara Cresci, Niccolò Marchionni and Stefano Giannini and has published in prestigious journals such as SHILAP Revista de lepidopterología, Diabetes Obesity and Metabolism and Diabetes Research and Clinical Practice.

In The Last Decade

Besmir Nreu

36 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Besmir Nreu Italy	20	869	398	265	149	137	36	1.1k
Fernando J. Lavalle‐González Mexico	17	948 1.1×	326 0.8×	374 1.4×	101 0.7×	61 0.4×	70	1.3k
Halil Önder Ersöz Türkiye	19	621 0.7×	148 0.4×	221 0.8×	43 0.3×	60 0.4×	56	1.2k
Martin Lange Spain	23	1.4k 1.7×	302 0.8×	499 1.9×	58 0.4×	70 0.5×	75	2.0k
Marja Pyörälä Finland	11	922 1.1×	311 0.8×	186 0.7×	66 0.4×	100 0.7×	35	1.6k
Brian Larsen Thorsted Denmark	14	1.4k 1.6×	339 0.9×	291 1.1×	64 0.4×	68 0.5×	22	1.6k
P. T. Sawicki Germany	20	764 0.9×	414 1.0×	255 1.0×	78 0.5×	157 1.1×	46	1.4k
Jon Rasmussen Denmark	16	722 0.8×	276 0.7×	146 0.6×	150 1.0×	20 0.1×	43	1.1k
Donald Pearson United Kingdom	16	855 1.0×	185 0.5×	446 1.7×	18 0.1×	66 0.5×	28	1.7k
S. P. Laing United Kingdom	12	988 1.1×	225 0.6×	427 1.6×	34 0.2×	102 0.7×	15	1.6k
Gary T.C. Ko Hong Kong	25	685 0.8×	188 0.5×	412 1.6×	68 0.5×	206 1.5×	66	1.5k

Countries citing papers authored by Besmir Nreu

Since Specialization

Citations

This map shows the geographic impact of Besmir Nreu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Besmir Nreu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Besmir Nreu more than expected).

Fields of papers citing papers by Besmir Nreu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Besmir Nreu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Besmir Nreu. The network helps show where Besmir Nreu may publish in the future.

Co-authorship network of co-authors of Besmir Nreu

This figure shows the co-authorship network connecting the top 25 collaborators of Besmir Nreu. A scholar is included among the top collaborators of Besmir Nreu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Besmir Nreu. Besmir Nreu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Masi, Davide, Fabio Baccetti, Besmir Nreu, et al.. (2024). Overcoming Therapeutic Inertia in Type 2 Diabetes: Exploring Machine Learning-Based Scenario Simulation for Improving Short-Term Glycemic Control. SHILAP Revista de lepidopterología. 6(1). 420–434. 1 indexed citations

Musacchio, Nicoletta, Davide Masi, Fabio Baccetti, et al.. (2024). A transparent machine learning algorithm uncovers HbA1c patterns associated with therapeutic inertia in patients with type 2 diabetes and failure of metformin monotherapy. International Journal of Medical Informatics. 190. 105550–105550. 1 indexed citations

Monami, Matteo, Benedetta Ragghianti, Besmir Nreu, et al.. (2022). Major Amputation In Non-Healing Ulcers: Outcomes and Economic Issues. Data from a Cohort of Patients with Diabetic Foot Ulcers. The International Journal of Lower Extremity Wounds. 24(1). 235–244. 7 indexed citations

Mannucci, Edoardo, Giovanni Targher, Besmir Nreu, et al.. (2022). Effects of insulin on cardiovascular events and all-cause mortality in patients with type 2 diabetes: A meta-analysis of randomized controlled trials. Nutrition Metabolism and Cardiovascular Diseases. 32(6). 1353–1360. 12 indexed citations

Valerio, Zeno Di, Marco Montalti, Federica Guaraldi, et al.. (2022). Trust of Italian healthcare professionals in COVID-19 (anti-SARS-COV-2) vaccination.. PubMed. 34(3). 217–226. 7 indexed citations

Dicembrini, Ilaria, et al.. (2020). Risk of cancer in patients treated with dipeptidyl peptidase-4 inhibitors: an extensive meta-analysis of randomized controlled trials. Acta Diabetologica. 57(6). 689–696. 42 indexed citations

Nreu, Besmir, et al.. (2020). Major cardiovascular events, heart failure, and atrial fibrillation in patients treated with glucagon-like peptide-1 receptor agonists: An updated meta-analysis of randomized controlled trials. Nutrition Metabolism and Cardiovascular Diseases. 30(7). 1106–1114. 65 indexed citations

Silverii, Giovanni Antonio, et al.. (2020). Bullous pemphigoid and dipeptidyl peptidase-4 inhibitors: a meta-analysis of randomized controlled trials. Endocrine. 69(3). 504–507. 19 indexed citations

Mannucci, Edoardo, Besmir Nreu, & Matteo Monami. (2020). Factors associated with increased all-cause mortality during the COVID-19 pandemic in Italy. International Journal of Infectious Diseases. 98. 121–124. 31 indexed citations

10.

Dicembrini, Ilaria, Besmir Nreu, Edoardo Mannucci, & Matteo Monami. (2019). Sodium‐glucose co‐transporter‐2 (SGLT‐2) inhibitors and cancer: A meta‐analysis of randomized controlled trials. Diabetes Obesity and Metabolism. 21(8). 1871–1877. 64 indexed citations

11.

Mannucci, Edoardo, Ilaria Dicembrini, Besmir Nreu, & Matteo Monami. (2019). Exploring the heterogeneity of the effects of SGLT-2 inhibitors in cardiovascular outcome trials. Nutrition Metabolism and Cardiovascular Diseases. 30(1). 71–76. 5 indexed citations

12.

Mannucci, Edoardo, Ilaria Dicembrini, Besmir Nreu, & Matteo Monami. (2019). Glucagon‐like peptide‐1 receptor agonists and cardiovascular outcomes in patients with and without prior cardiovascular events: An updated meta‐analysis and subgroup analysis of randomized controlled trials. Diabetes Obesity and Metabolism. 22(2). 203–211. 42 indexed citations

13.

Dicembrini, Ilaria, et al.. (2019). Nephrolithiasis and sodium-glucose co-transporter-2 (SGLT-2) inhibitors: A meta-analysis of randomized controlled trials. Diabetes Research and Clinical Practice. 155. 107808–107808. 16 indexed citations

14.

Dicembrini, Ilaria, Besmir Nreu, Alessia Scatena, et al.. (2017). Microvascular effects of glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized controlled trials. Acta Diabetologica. 54(10). 933–941. 63 indexed citations

15.

Monami, Matteo, Ilaria Dicembrini, Besmir Nreu, et al.. (2017). Predictors of response to glucagon-like peptide-1 receptor agonists: a meta-analysis and systematic review of randomized controlled trials. Acta Diabetologica. 54(12). 1101–1114. 26 indexed citations

16.

Monami, Matteo, Besmir Nreu, Alessia Scatena, et al.. (2017). Safety issues with glucagon‐like peptide‐1 receptor agonists (pancreatitis, pancreatic cancer and cholelithiasis): D ata from randomized controlled trials. Diabetes Obesity and Metabolism. 19(9). 1233–1241. 177 indexed citations

17.

Monami, Matteo, et al.. (2017). Effects of SGLT-2 inhibitors on diabetic ketoacidosis: A meta-analysis of randomised controlled trials. Diabetes Research and Clinical Practice. 130. 53–60. 76 indexed citations

18.

Monami, Matteo, Alessia Scatena, Besmir Nreu, et al.. (2017). CO2 laser for the treatment of diabetic foot ulcers with exposed bone. A consecutive series of type 2 diabetic patients. Journal of Endocrinological Investigation. 40(8). 819–822. 9 indexed citations

19.

Monami, Matteo, Stefania Zannoni, Besmir Nreu, & Edoardo Mannucci. (2016). Toe amputations with SGLT-2 inhibitors: data from randomized clinical trials. Acta Diabetologica. 54(4). 411–413. 10 indexed citations

20.

Monami, Matteo, et al.. (2014). A meta‐analysis of the hypoglycaemic risk in randomized controlled trials with sulphonylureas in patients with type 2 diabetes. Diabetes Obesity and Metabolism. 16(9). 833–840. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact